Condition (MeSH)
Bird Diseases
ClinicalTrials.gov lists 98 trials for Bird Diseases or a narrower condition beneath it. National Institute of Allergy and Infectious Diseases (NIAID) has the most among industry and government lead sponsors, with 45.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
When did Bird Diseases trials start? (19)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Observational
Top of scale: 15
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 4 |
| 2024 | 1 |
| 2022 | 1 |
| 2018 | 8 |
| 2017 | 4 |
| 2016 | 4 |
| 2015 | 1 |
| 2014 | 5 |
| 2013 | 7 |
Showing 10 of 19 earlier years.
No forecast is made for this condition: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Bird Diseases trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 43 |
| Phase 1/2 | 11 |
| Phase 2 | 28 |
| Phase 2/3 | 2 |
| Phase 3 | 6 |
| Phase 4 | 1 |
| Not applicable | 1 |
| Observational | 6 |
How many Bird Diseases trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 2 |
| Completed | 90 |
| Terminated | 2 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Bird Diseases trials? (13)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 45 |
| Novartis Vaccines | 8 |
| Seqirus | 4 |
| Alachua Government Services, Inc. | 3 |
| Biomedical Advanced Research and Development Authority | 2 |
Showing 5 of 13 sponsors.
Which drugs are being tested for Bird Diseases? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| AS03 | 10 |
| Oseltamivir | 3 |
Interventions as named in the registry (13)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| MF59 Adjuvant | 4 |
| MF59 | 4 |
| Inactivated Influenza A/H5N1 Vaccine (Chiron) | 4 |
| VRC-AVIDNA036-00-VP | 4 |
| H5N1 Vaccine | 3 |
Showing 5 of 13 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Bird Diseases trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Osteoarthritis | 20 | 2 |
| Atrial fibrillation | 16 | 1 |
| ATRIAL FIBRILLATION | 11 | 2 |
| OSTEOARTHRITIS | 10 | 1 |
| PNEUMONIA | 10 | 3 |
Showing 5 of 10 adverse events.
Which publications cover Bird Diseases? (11)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| ASSESSING THE HUMORAL RESPONSE TO AND SAFETY OF A COMMERCIALLY AVAILABLE EQUINE WEST NILE VIRUS VACCINE IN A ZOO-BASED CONSERVATION BREEDING POPULATION OF ENDANGERED GREATER SAGE-GROUSE (<i>CENTROCERCUS UROPHASIANUS</i>). | Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians | 2021 | Yes |
| Genomic monitoring to understand the emergence and spread of Usutu virus in the Netherlands, 2016-2018. | Scientific reports | 2020 | Yes |
| An overview of Usutu virus. | Microbes and infection | 2017 | Yes |
| Widespread Usutu virus outbreak in birds in the Netherlands, 2016. | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2016 | Yes |
| Newcastle disease and other avian paramyxoviruses. | Revue scientifique et technique (International Office of Epizootics) | 2000 | Yes |
Showing 5 of 11 publications.
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.